Evidence map›Paper›PMID 36934441›Full record

ArticleJournal of applied clinical medical physics2023

Film measurement and analytical approach for assessing treatment accuracy and latency in a magnetic resonance-guided radiotherapy system.

Hiroki Nakayama, Hiroyuki Okamoto, Satoshi Nakamura, Kotaro Iijima, Takahito Chiba, Mihiro Takemori, Tetsu Nakaichi, Shohei Mikasa, Kyohei Fujii, Tatsuya Sakasai and 7 more

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hiroki NakayamaRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9491-787X
Hiroyuki OkamotoRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Satoshi NakamuraRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kotaro IijimaRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1691-0175
Takahito ChibaRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Mihiro TakemoriRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Tetsu NakaichiRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-6885-4892
Shohei MikasaRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kyohei FujiiDepartment of Radiation Sciences, Komazawa University, Setagaya-ku, Tokyo, Japan.
Tatsuya SakasaiDepartment of Radiological Technology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Junichi KuwaharaRadiation Safety and Quality Assurance Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Yuki MiuraDepartment of Radiological Technology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Daisuke FujiyamaDepartment of Radiological Technology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Yuki TsunodaDepartment of Radiological Technology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Takuma HanzawaDepartment of Radiological Technology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Hiroshi IgakiDepartment of Radiation Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Weishan ChangDepartment of Radiological Sciences, Graduate School of Human Health Sciences, Tokyo Metropolitan University, Higashioku, Arakawa-ku, Tokyo, Japan.

Funding

AMED 22ck0106745h0001Grant-in-Aid for Young Scientists 18K15613National Cancer Center Research and Development Fund 2022-A-18
6 · The paper itself

Abstract

purposeWe measure the dose distribution of gated delivery for different target motions and estimate the gating latency in a magnetic resonance-guided radiotherapy (MRgRT) system.

methodThe dose distribution accuracy of the gated MRgRT system (MRIdian, Viewray) was investigated using an in-house-developed phantom that was compatible with the magnetic field and gating method. This phantom contains a simulated tumor and a radiochromic film (EBT3, Ashland, Inc.). To investigate the effect of the number of beam switching and target velocity on the dose distribution, two types of target motions were applied. One is that the target was periodically moved at a constant velocity of 5 mm/s with different pause times (0, 1, 3, 10, and 20 s) between the motions. During different pause times, different numbers of beams were switched on/off. The other one is that the target was moved at velocities of 3, 5, 8, and 10 mm/s without any pause (i.e., continuous motion). The gated method was applied to these motions at MRIdian, and the dose distributions in each condition were measured using films. To investigate the relation between target motion and dose distribution in the gating method, we compared the results of the gamma analysis of the calculated and measured dose distributions. Moreover, we analytically estimated the gating latencies from the dose distributions measured using films and the gamma analysis results.

resultsThe gamma pass rate linearly decreased with increasing beam switching and target velocity. The overall gating latencies of beam-hold and beam-on were 0.51 ± 0.17 and 0.35 ± 0.05 s, respectively.

conclusionsFilm measurements highlighted the factors affecting the treatment accuracy of the gated MRgRT system. Our analytical approach, employing gamma analysis on films, can be used to estimate the overall latency of the gated MRgRT system.

Indexed as

Radiotherapy Planning, Computer-AssistedHumansMagnetic Resonance SpectroscopyMotionPhantoms, ImagingRadiotherapy Dosagegating methodlatencymagnetic resonance-guided radiotherapyquality assurance

Identifiers

PMID36934441
PMCPMC10161048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.